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After an epidemic of serogroup A meningococcal meningitis in northern Ghana, a gradual dis-
appearance of the epidemic strain was observed in a series of five 6-month carriage surveys of 37
randomly selected households. As serogroup A Neisseria meningitidis carriage decreased, an epi-
demic of serogroup X meningococcal carriage occurred, which reached 18% (53/298) of the
people sampled during the dry season of 2000, coinciding with an outbreak of serogroup X dis-
ease. These carriage patterns were unrelated to that of Neisseria lactamica. Multilocus sequence
typing and pulsed-field gel electrophoresis of the serogroup X bacteria revealed strong similarity
with other strains isolated in Africa during recent decades. Three closely related clusters with
distinct patterns of spread were identified among the Ghanian isolates, and further microevolu-
tion occurred after they arrived in the district. The occurrence of serogroup X outbreaks argues
for the inclusion of this serogroup into a multivalent conjugate vaccine against N. meningitidis.
Neisseria meningitidis can be classified into>13 distinct sero-
groups on the basis of the antigenicity of the polysaccharide
capsule [1]. Serogroups A, B, and C are responsible for .90%
of invasive meningococcal infections worldwide. Most large
meningitis epidemics are caused by serogroup A meningococci.
Since World War II, such epidemics have been rare in industri-
alized countries but they occur periodically in the African men-
ingitis belt and in China [2–6]. Serogroup C meningococci also
cause disease outbreaks and occasionally epidemics [7, 8]. En-
demic disease usually is caused by meningococci belonging to
serogroup B or C, but occasionally disease is caused by bacteria
in other serogroups, including W135, Y, and X. N. meningitidis
serogroup X was described in the 1960s [9, 10], and a limited
number of serogroup X meningococcal disease cases have been
reported in North America [11], Europe [12, 13], Australia [14],
and Africa [15, 16]. Some have been associated with comple-
ment deficiencies [17, 18] or AIDS [19]. Recently, 2 outbreaks
of serogroup X meningococci occurred in Niger [20, 21]. Sero-
group X bacteria were found to be very efficient in colonizing a
group of military recruits in the United Kingdom [22].
In the African meningitis belt, epidemics of serogroup A
meningococci occur in cycles every 8–12 years, and each epi-
demic wave follows a multiyear crescendo-decrescendo pattern
[23]. Disease incidence is seasonally dependent, peaking during
the dry season (December–May) and declining rapidly with
the onset of the rainy season [24]. Even during major epidemic
waves, case numbers are low during the rainy season [23]. The
underlying mechanisms leading to the spread of meningococci
and to epidemics of meningococcal disease remain unknown.
Carriage rates of 15% can occur during epidemics in Africa [25,
26]. A population’s susceptibility to epidemic disease might re-
turn as antibody levels decline and herd immunity is diluted by
new birth cohorts and migration [23]. Variation in virulence
between strains of N. meningitidis and the introduction of a new
meningococcal clone into a susceptible population also might
contribute to an epidemic. The extreme environmental conditions
present in the sub-Saharan meningitis belt during the dry sea-
son—high temperature, low absolute humidity, and the Harmat-
tan (a dusty wind that blows from the Sahara)—plus respiratory
coinfections are thought to contribute to an enhanced suscepti-
bility to meningococcal disease by damaging the local mucosal
defenses [23].
Most persons infected with meningococci are only colonized.
They carry the bacteria asymptomatically in the nasopharynx,
and only a small proportion of these carriers develop invasive
meningococcal disease. Therefore, epidemiologic analysis of
meningococcal infection in defined populations should include
both carrier and case patient studies. However, even carriage
studies probably detect only a small proportion of the strains col-
onizing humans [27]. Meningococci can acquire foreign genes
by DNA transformation from unrelated bacteria, including com-
mensal neisseriae [28]. Serologic cross-reactions between Neis-
seria lactamica and N. meningitidis have been demonstrated,
and it has been argued that the carriage of N. lactamica may
have a role in the development of natural immunity to meningo-
coccal disease [29]. Despite the importance of meningococcal
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infection as a cause of morbidity and mortality in countries of
the African meningitis belt, few longitudinal carriage studies
have been undertaken in this region [25, 26].
In the dry seasons between November 1996 and May 1997, a
meningitis epidemic occurred in northern Ghana [30]. In total,
18,551 cases and 1403 deaths were reported [31]. During the
1996–1997 epidemic, 1396 cases and 65 deaths were registered
in the Kassena-Nankana District (KND; Upper East Region)
[32]. One year later, a smaller meningitis outbreak occurred in
the same district with 50 serogroup A subgroup III cases and 10
deaths [16]. To investigate the dynamics of meningococcal car-
riage, we conducted a longitudinal carriage study in the KND dur-
ing 1998–2000 when an outbreak of serogroup X meningococcal
meningitis with a high carriage rate occurred.
Methods
Study area and population. The study was conducted in the
KND of the Upper East Region of Ghana. The district lies within
the guinea savannah woodland area, has a population of 140,000,
and has 2 main seasons: a short wet season from June to October
and a long dry season the rest of the year. The general population
is rural except for those living in the town of Navrongo (population
20,000). People live in residential compounds with an average of
10 inhabitants each.
Suspected meningitis patients presenting at the War Memorial
Hospital, Navrongo, or at 1 of the 3 health centers in the KND
were recruited throughout the study period. In accordance with
World Health Organization guidelines [5], a suspected case was de-
fined by sudden onset of fever and stiff neck or fever and stiff neck
and altered mental status. A lumbar puncture was done before treat-
ment, and the cerebrospinal fluid specimen was analyzed as de-
scribed elsewhere [16]. Because of the 1997 epidemic and the var-
ious vaccination campaigns in KND, the population was clearly
attuned to the danger of meningitis, and most patients were likely
to present at a health facility.
Residential compounds were selected randomly from a complete
listing of the district population (Navrongo Demographic Surveil-
lance System [33]). One compound refused to participate and was
replaced by the next eligible one on the random listing. The 37 se-
lected compounds were sampled 5 times between March 1998 and
April 2000, once in each dry and rainy season. At the time of the visit,
a throat swab was taken from all compound members who agreed to
participate. The swabs were inoculated directly on Thayer-Martin
agar plates (Difco) that were transported to a laboratory within 2
h. The agar plates were incubated in candle jars for 24 h at 37C.
Characterization of bacteria. Up to 10 random colonies with
neisserial morphology were subcultured from each plate. Bacteria
that were gram-negative diplococci that produced cytochrome oxi-
dase from N,N,N0,N0-tetramethyl-1,4-phenylene-diammoniumdi-
chloride (Merck) and utilized glucose and maltose but not sucrose
in cystine-trypticase agar (Difco) were analyzed further. Those with
b galactosidase (ONPG disks; Oxoid) were classified as N. lacta-
mica, and those with g-glutamyltransferase activity (MPR 2-kit;
Boehringer Mannheim) were classified as N. meningitidis. Isolates
from these species were stored in 10% skim milk (Difco) on glass
beads at 270C. The frozen samples were transported to Switzer-
land in liquid nitrogen or on dry ice.
Meningococci were serogrouped by slide agglutination with
serogroup-specific antisera (Murex) and were serotyped or sub-
typed with monoclonal antibodies by whole cell ELISA [4]. They
also were screened for diversity by pulsed-field gel electrophoresis
(PFGE) after digestion with Nhe I and Spe I [34]. Multilocus se-
quence typing (MLST) was performed [35] on a subset of 20 iso-
lates representing the different PFGE variants of the different
serogroups.
Data analysis. We calculated the prevalence of carriage with
STATA statistical software [36]. To evaluate age and sex effects
on prevalence, we used logistic regression models including ran-
dom effects, to allow for repeated assessment of the same persons.
The incidence (acquisition) of carriage was estimated by using paired
samples from successive surveys with the following formula: num-
ber of new acquisitions=ðperson-intervals at risk £ duration of in-
terval). The person-intervals at risk were defined as pairs of sam-
ples where bacteria were not present in the first sample, and new
acquisitions were defined as pairs in which bacteria were present
in the second sample. Age and sex effects on incidence of infection
(acquisition) were assessed by logistic regression analysis.
For serogroup X isolates, distinct Nhe I and Spe I fragments were
assigned arbitrary numbers. The presence or absence of each frag-
ment was scored in a data matrix as plus (1) or minus (0). We used
the data matrix to construct a neighbor-joining tree (MEGA version
2b3 [37]) based on the number of band differences between PFGE
patterns. For serogroup X strains, a matrix of pairwise geographic
distances between the compound of isolation was compared with
the data matrix of genetic distances by a Mantel test with 10,000
permutations (GENETIX version 4.01 [38]).
Results
The longitudinal carriage rate of N. meningitidis and N. lacta-
mica was investigated between 1998 and 2000 in the KND.
Throat swabs taken on 5 occasions from 292–308 inhabitants of
37 randomly selected residential compounds were investigated
bacteriologically. Only 2 persons refused to participate further
after the first survey and were excluded from the analysis. Over-
all, 493 persons (43% males) participated in the study. The mean
age of the participants was 25 years (SD, 20 years). The study
population did not get older because we also recruited babies.
Retrospective questionnaire responses regarding immunization
with A/C polysaccharide were available for 377 participants
(76%). The estimated vaccine coverage in KND was 84%.
Prevalence and incidence of carriage. The carriage rate of
N. lactamica remained constant at 9% with no difference be-
tween the dry and the wet season. However, the carriage rate of
N. meningitidis of different serogroups changed dramatically.
Carriage of serogroup A meningococci dropped continuously
from 3% in April 1998 to<0.3% in April 2000 (table 1). All 14
serogroup A isolates were A:4,21:P1.9 and possessed PFGE
patterns similar to those of disease isolates from the 1998 men-
ingitis outbreak (data not shown). Three representative isolates
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were MLST sequence type ST5, as is typical of subgroup III bac-
teria from Africa [39].
Serogroup X bacteria were first isolated in 1999 (3% of sam-
ples) and comprised 18% of samples in the dry season of 2000
(table 1). The estimated incidence (acquisition rate) was 0.6 per
100 person months for N. lactamica, 1.0 for serogroup X menin-
gococci, and 0.2 for meningococci of other serogroups (table 2).
The carriage rate of N. lactamica was highest among children
,5 years old and decreased continuously with age (figure 1). In
contrast, serogroup X carriage was highest among 5–14-year-
olds. Females were more likely to acquire N. lactamica (table 2).
Males were at higher risk of carrying serogroup X meningococ-
ci than were females (odds ratio [OR], 2.0; 95% confidence in-
terval [CI], 1.2–3.3), but there was no significant difference in
acquisition (table 2). Males were also more likely to carry (OR,
3.9; 95% CI, 1.4–10.9) and to acquire meningococci of other
serogroups (table 2).
Only 3 persons were colonized simultaneously by N. men-
ingitidis and N. lactamica, which was fewer than expected, as-
suming independence (P , :02, Fisher’s exact test). However,
persons carrying N. lactamica at any one time were equally likely
to become serogroup X carriers in subsequent surveys as those
who did not carry N. lactamica. The acquisition of serogroup
X bacteria did not differ significantly between compounds with
N. lactamica carriers and compounds without carriers.
People living in compounds with >1 N. lactamica carrier
were more likely to acquire N. lactamica (secondary coloniza-
tion) than were persons living in compounds without carriers
(OR, 5.0; CI 95%, 2.1–12.1). As expected for an epidemic out-
break, most persons from whom serogroup X bacteria were iso-
lated lived in compounds where these organisms had not been
recovered previously. Nearly 60% of the compounds sampled
became newly infected with serogroup X bacteria at some
point during the study. On average, 35% of a compound’s
inhabitants (2:5 ^ 2:0 persons; range, 1–8 persons) carried sero-
group X meningococci on the first occasion that the bacteria
were detected in that compound. Vaccination with A/C polysac-
charide had no effect on colonization with serogroup X.
Cases of meningococcal meningitis. The last confirmed sero-
group A meningococcal meningitis case occurred in the second
epidemic year—during the 1998 dry season [16]. In contrast, 9
cases (56% in males) of meningitis were caused by serogroup X
meningococci from March 1998 to April 2000. One of these
cases occurred in the 1998 dry season during the serogroup A
outbreak and was fatal. A second fatal case occurred during the
1999 dry season. During the 2000 dry season, 7 patients were
identified and all survived. The median age of the 9 patients
was 6 years (mean, 9.7 years; range, 1–32 years). Serogroup
X disease was not associated with complement or properdin
deficiency in any of the 4 serum samples tested [41].
Table 2. Sex differences in incidence (acquisition) of carriage of Neisseria lactamica and different sero-
groups of Neisseria meningitidis (per 100 person months) estimated from sequential samples.
Serogroup acquired Total Malesa Femalesa
Age-adjusted
odds ratio LRT x1
2 P
Serogroup X 1.0 (0.7–1.3) 1.2 (0.8–1.7) 0.8 (0.5–1.1) 1.6 (0.9–2.7) 2.4 .12
Other serogroups 0.2 (0.1–0.4) 0.3 (0.1–0.6) 0.1 (0.02–0.3) 3.4 (0.9–12.8) 3.6 .06
N. lactamica 0.6 (0.4–0.8) 0.3 (0.1–0.6) 0.8 (0.5–1.2) 0.4 (0.2–0.9) 6.0 ,.02
NOTE. Data are odds ratio (95% confidence interval). LRT, likelihood ratio test from logistic regression.
a Binomial exact odds ratio.
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N. lactamica — — 28 (9.3) 26 (8.7) 24 (8.2) 30 (9.7) 25 (8.4) 133 (8.9) — — NS
N. meningitidis — — 14 (4.7) 9 (3.0) 15 (5.1) 13 (4.2) 59 (19.8) 110 (7.4) 100
A:4,21:P1.9 ST5 III 9 (3.0)a 4 (1.3)b 2 (0.7) 1 (0.3) 0 (,0.3) 16 (1.1)a,b 14.5 15.6 ,.001
X:NT:P1.5 ST181/ST751 — 0 (,0.3) 0 (,0.3) 10 (3.4) 7 (2.3)a 53 (17.8)a 70 (4.7) 63.6 94.3 ,.001
Y:4:P1.5 ST168 — 4 (1.3) 3 (1.0)a 2 (0.7) 3 (1.0)a 5 (1.7)a 17 (1.1)d 15.5 — NS
W135:2a:P1.2,5 ST11 ET-37 1 (0.3) 1 (0.3) 0 (,0.3) 0 (,0.3) 0 (,0.3) 2 (0.1) 1.8
PolyAG:NT:NST ND — 0 (,0.3) 1 (0.3) 1 (0.3) 2 (0.6) 1 (0.3) 5 (0.3) 4.5
NOTE. Data are no. (%) of subjects, except where noted. DS, dry season; LRT, likelihood ratio test from logistic regression; MLST, multilocus sequence typ-
ing; ND, not done; NS, not significant; NST, nonsubtypeable; NT, nontypeable; polyAG, polyagglutinable; RS, rainy season.
a PolyAG, 1 isolate.
b Nongroupable, 1 isolate.
c PolyAG, 2 isolates.
d PolyAG, 3 isolates.
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Population structure and spread of serogroup X meningococci.
We obtained serogroup X meningococcal isolates from Africa
(dating from 1970 to 2000); all the isolates, including both dis-
ease and carrier isolates, could be assigned to 2 groups, a and b,
by PFGE (authors’ unpublished data). Most serogroup X iso-
lates from Chad, Mali, and Niger were group a; strains from
Burkina Faso were group b. These PFGE patterns differ in 4
Nhe I and 3 Spe I fragments. Of the 79 serogroup X isolates from
Ghana, 78 belonged to group b and 1 belonged to group a (figure 2,
track 14 ). The group a isolate was MLST type ST181; 12 rep-
resentative group b isolates were ST751, which differs at 2 of
the 7 MLST loci. The group b isolates from Ghana were not totally
uniform by PFGE. They shared 11 uniform Nhe I bands (figure
2), but 8 other bands were polymorphic. Four smaller fragments
could not be evaluated because of lack of resolution. Similarly,
the group b isolates contained 19 uniform Spe I fragments, 6 that
Figure 1. Age distribution by prevalence of carriage of Neisseria lactamica and different serogroups of Neisseria meningitidis. Error bars in-
dicate 95% confidence intervals on the basis of a logistic model that allowed for repeated measurements with the SAS GENMOD procedure [40].
Figure 2. Pulsed-field geld electrophoresis patterns of Nhe I- and Spe I-digested chromosomal DNA of representative serogroup X meningo-
cocci from northern Ghana. Strains were loaded in tracks 1–19 in the following order (track, strain): 1, Z9389; 2, Z9396; 3, Z9381; 4, Z9292; 5,
Z9295; 6, Z9399; 7, Z9401; 8, Z8329; 9, Z8331; 10, Z9301; 11, Z9300; 12, Z9297; 13, Z9383; 14, Z9413; 15, Z9294; 16, Z7091; 17, Z8336; 18,
Z9392; and 19, Z9293. Molecular weight markers were loaded in the flanking tracks as indicated (LM, low range marker; MM, midrange marker).
Molecular weights are at left.
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were polymorphic, and 3 that could not be evaluated. The com-
bined data from both restriction digests resulted in 9 PFGE sub-
types within the group b Ghanaian isolates (figure 2).
Phylogenetic analysis of the PFGE data showed that 8 of the
9 subtypes from group b belonged to 3 clusters (1–3) and that 1
subtype represented by the sole isolate from 1998 was very dif-
ferent. Both neighbor-joining (figure 3) and maximal parsimony
algorithms (data not shown) yielded comparable results. For the
cluster 1–3 isolates, there was significant correlation between
the pairwise genetic distances and the geographic distances be-
tween the compounds of isolation (Pearson r ¼ 0:34; P , :0001,
Mantel test). The correlation was even stronger between geograph-
ic distances and cluster assignment (Pearson r ¼ 0:43; P ,
:0001, Mantel test). All 3 clusters were isolated from both car-
riers and meningitis patients (cluster 1, 4 patients; cluster 2, 1
patient; and cluster 3, 3 patients). There was no significant dif-
ference in the patient:healthy carrier ratio among clusters.
All 3 clusters were found in 1999. Clusters 1 and 3 also were
isolated in Burkina Faso from 1996 to 1998 (figure 3). These re-
sults suggest that the 3 clusters evolved outside the district and
were imported concomitantly in 1999. The 3 clusters showed dif-
ferent patterns of spread. Cluster 1 bacteria colonized only 1 com-
pound in 1999 and spread extensively through the central part of
the district in 2000 (figure 4). Cluster 2 colonized a few com-
pounds in the eastern part of the district in 1999 and spread to
only 3 other compounds thereafter. Cluster 3 spread from east
to west and continued to diversify (figure 3). Cluster 3 isolates
from 1999 and Burkina Faso (1998) were located in branches
nearer the root of the tree and seem to be ancestral. Most cluster
3 isolates from 2000 were in descendent twigs, indicating recent
descent.
Discussion
Meningococcal carriage rates of up to 30% are observed
during serogroup A epidemics in Africa [23], but lower carriage
rates have occurred in some epidemics [42], and carriage is gen-
erally infrequent during interepidemic periods [8, 25, 26]. A
major serogroup A epidemic occurred in northern Ghana in
1996–1998 [16]. The data presented here show that, in 1998,
the carriage prevalence of the epidemic strain was only 3%.
During the following 2 years, serogroup A carriage decreased
even further, and no serogroup A carrier was identified in 2000.
These results resemble those for a serogroup A subgroup IV-1
epidemic in The Gambia in the 1980s [26].
There was an initial increase in carriage of serogroup X dur-
ing the 1999 dry season followed by a second strong increase
during the 2000 dry season. Season has no effect on meningo-
coccal carriage in temperate zones and in Africa [24, 43, 44]
and is, therefore, unlikely to account for the observed increase
in serogroup X carriage. In contrast, similar temporal patterns
are typical of serogroup A epidemics in the African meningitis
belt, where large epidemics are often preceded by localized out-
breaks 1 year earlier [23]. The prevalence of serogroup X car-
riage was highest in 10–14-year-olds, which is similar to the age
patterns frequently observed for both serogroup A carriage and
disease [45]. Although there were sex differences in carriage
prevalence and incidence in N. lactamica and meningococci
of other serogroups, there was no such difference in acquisition
of serogroup X bacteria, reflecting the epidemic nature of the
colonization process—that is, the whole population was at risk.
Furthermore, serogroup X meningococci were acquired mostly
through primary colonization, which suggests that a new bac-
terial wave was entering the area.
Our findings are consistent with the hypothesis that, in the
African meningitis belt, meningococci of different serogroups
invade specific populations in successive waves. Low carriage
rates during interepidemic periods alternate with periods of high
carriage, which can result in epidemics of disease if the bacteria
are particularly virulent. However, frequent carriage of bacteria
of low virulence normally would not be documented because of
the low burden of disease. The ratio of cases of serogroup A disease
per carrier in 1998 was 40-fold higher than that for serogroup X
meningococci in 2000. These different case-to-carriage ratios
possibly reflect such differences in virulence. However, it has
been postulated that epidemic disease reflects a lack of herd im-
munity [23], and it is possible that carriage of serogroup A bac-
teria during 1996–1998 stimulated protective immunity against
subsequent disease by serogroup X meningococci. Secondary
factors, such as respiratory tract coinfections, also may be neces-
sary for epidemics to occur [8] and might have been lacking during
the epidemic of colonization by serogroup X meningococci. Me-
ningococcal disease (as opposed to carriage) is highly seasonal in
the African meningitis belt [24], and all 9 cases of meningococcal
meningitis in our study occurred exclusively during the dry season.
It has been suggested that exposure to N. lactamica may stim-
ulate natural immunity to meningococcal disease [29, 43]. A neg-
ative correlation between carriage of N. lactamica and either
carriage of N. meningitidis or meningococcal disease was found
in the Faroe Islands [46]. In one African study involving N. lac-
tamica, there was no association between carriage of N. menin-
gitidis and N. lactamica [25]. We found a negative association
between the carriage of both species in this study. However, car-
riage of N. lactamica did not correlate with the acquisition of
serogroup X meningococci or its absence, either at the individ-
ual or the compound level. Thus, it appears that, in the African
meningitis belt, carriage of N. lactamica does not reduce coloni-
zation of the nasopharynx with serogroup X meningococci but
could still protect against serogroup A infections. The age and
sex patterns of prevalence and acquisition of N. lactamica dif-
fered from those of N. meningitidis. N. lactamica was carried
predominantly by infants and young children, which is similar
to data from Europe and other African studies [25, 43, 46, 47].
N. lactamica was acquired mainly in compounds where carriers
were already present, indicating that it is transmitted from per-
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Figure 3. Neighbor-joining tree based on the pulsed-field gel electrophoresis subtypes of serogroup X meningococci isolated in northern Ghana.
Distance used was no. of band differences. Nos. at nodes are percentages of 1000 bootstrap replicates in which the nodes appeared. Only nodes
with .50% are indicated. Strains labeled “D” or “R” were isolated during the dry or rainy seasons, respectively.
Figure 4. Spatial distribution of housing compounds with carriers of serogroup X Neisseria meningitidis and Neisseria lactamica at different time points. Black dots indicate com-
pounds sampled. Red, yellow, and green dots indicate compounds in which serogroup X N. meningitidis carriers were identified. The colors correspond to the 3 clusters identified by phylo-
genetic analysis (figure 3). Colored triangles, compounds in which meningitis cases were identified; gray circles, compounds with N. lactamica carriers.
son to person within compounds and that recolonization prob-
ably is frequent.
The serogroup X meningococci that colonized the KND popu-
lation have been isolated in West Africa for >3 decades (au-
thors’ unpublished data). Bacteria belonging to the same clonal
grouping caused a meningitis outbreak with.60 cases in Niger
in 1997, although, during that period, most of the meningococcal
meningitis cases were caused by serogroup A [21] (authors’ un-
published data). Some microheterogeneity was found among the
Ghanaian serogroup X isolates. The different PFGE types iden-
tified clustered in 3 phylogenetic clusters that did not differ in
virulence but exhibited very distinct patterns of dispersal. Clus-
ter 1 spread extensively without genetic diversification. Cluster 2,
which was more diverse than cluster 1, colonized only a few com-
pounds and did not spread further. Cluster 3 spread and diversi-
fied during the process.
Although serogroups A, B, and C are responsible for .90%
of meningococcal disease worldwide, recent outbreaks of sero-
group X and W-135 meningococci illustrate that these sero-
groups also have considerable pathogenic potential [20, 21,
48]. In Streptococcus pneumoniae, the introduction of polyvalent
capsule polysaccharide conjugate vaccines seems to have in-
duced changes in bacterial population structure of carrier iso-
lates [49, 50]. The effects of widespread immunization with con-
jugate polysaccharide vaccines on the population structure of
meningococci is also under discussion [51]. Selection can lead
to frequent isolation of escape variants [28, 39]. It is possible
that the mass vaccination with A/C polysaccharide in 1997
and 1998 in northern Ghana might have contributed to the colo-
nization and disease by serogroup X. Although serogroup X
usually causes only a small proportion of meningococcal dis-
ease, repeated vaccination against serogroups A and C in
many African countries has the potential to select meningococci
of other serogroups (e.g., serogroup X) and might result in a
changed profile of meningococcal disease. This possibility
should be considered when conjugate vaccines carrying limited
ranges of serogroups are introduced. It is important that more
comprehensive conjugate vaccines that include X polysaccha-
ride be developed as soon as possible.
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